In addition, expression levels of CDH1, CDKN1A, and EP300 were reduced while expression levels of RhoA, ROCK1, ROCK2, PIK3CA, and CCND1 were increased in gastric cancer tissues with reduced or loss of NKX6.3 expression (Fig. 6). Here, EP300 is linked to gastric cancer.